Comparison of efficacy of diclofenac and tramadol in relieving pain in patients of acute pancreatitis: A randomized parallel group double blind active controlled pilot study.
acute pancreatitis
complications
diclofenac
pain
tramadol
Journal
European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
18
07
2019
revised:
22
11
2019
accepted:
25
11
2019
pubmed:
30
11
2019
medline:
21
11
2020
entrez:
30
11
2019
Statut:
ppublish
Résumé
Opioids and non steroidal anti inflammatory drugs (NSAIDs) are commonly used for pain relief in acute pancreatitis (AP). Opioids carry risk of sphincter of oddi constriction. Although diclofenac prevents post endoscopic retrograde cholangio-pancreatography (ERCP) pancreatitis, few reports of diclofenac associated AP are also present. Although, both tramadol and diclofenac are commonly used for pain relief in AP, no study has evaluated their comparative efficacy and safety. Forty-six eligible participants were randomized to either diclofenac or tramadol. Primary objectives of our study were improvement in pain intensity on visual analogue scale (VAS pain score after 1 hr of drug administration) and number of patients requiring supplementary analgesia. The secondary objectives were total number of times of supplementary analgesia requirement, time to significant decrease (33%) in VAS pain score from baseline, number of painful days (VAS pain score >5), VAS pain score on 7th day, side effects, all cause death and complications of pancreatitis between the two groups. Although 46 patients were randomized, the final analysis included 41 participants. Five patients were withdrawn from the study (intubation = 3, altered sensorium = 2). No significant difference was seen in terms of VAS score after 1 hr of drug administration, number of patients requiring supplementary analgesic and number of painful days. However, time taken to significant reduction of pain was lower in the diclofenac group (p = .028). Both the agents were comparable in terms of safety. Although complications were less in the diclofenac group, the difference was not statistically significant. Both diclofenac and tramadol are equally effective in controlling pain in AP with similar safety profile. There are no studies that have compared the safety and efficacy of two commonly used analgesics for pain relief in patients with AP. We found that both diclofenac and tramadol are equally effective in decreasing the pain associated with AP. There is also no significant difference in the incidence of side effects between both the groups. Hence both diclofenac and tramadol can be used safely and effectively for pain control in AP. The trial was registered with clinical trials registry India (Number- CTRI/2018/05/014309).
Sections du résumé
BACKGROUND
Opioids and non steroidal anti inflammatory drugs (NSAIDs) are commonly used for pain relief in acute pancreatitis (AP). Opioids carry risk of sphincter of oddi constriction. Although diclofenac prevents post endoscopic retrograde cholangio-pancreatography (ERCP) pancreatitis, few reports of diclofenac associated AP are also present. Although, both tramadol and diclofenac are commonly used for pain relief in AP, no study has evaluated their comparative efficacy and safety.
MATERIALS AND METHODS
Forty-six eligible participants were randomized to either diclofenac or tramadol. Primary objectives of our study were improvement in pain intensity on visual analogue scale (VAS pain score after 1 hr of drug administration) and number of patients requiring supplementary analgesia. The secondary objectives were total number of times of supplementary analgesia requirement, time to significant decrease (33%) in VAS pain score from baseline, number of painful days (VAS pain score >5), VAS pain score on 7th day, side effects, all cause death and complications of pancreatitis between the two groups.
RESULTS
Although 46 patients were randomized, the final analysis included 41 participants. Five patients were withdrawn from the study (intubation = 3, altered sensorium = 2). No significant difference was seen in terms of VAS score after 1 hr of drug administration, number of patients requiring supplementary analgesic and number of painful days. However, time taken to significant reduction of pain was lower in the diclofenac group (p = .028). Both the agents were comparable in terms of safety. Although complications were less in the diclofenac group, the difference was not statistically significant.
CONCLUSION
Both diclofenac and tramadol are equally effective in controlling pain in AP with similar safety profile.
SIGNIFICANCE
There are no studies that have compared the safety and efficacy of two commonly used analgesics for pain relief in patients with AP. We found that both diclofenac and tramadol are equally effective in decreasing the pain associated with AP. There is also no significant difference in the incidence of side effects between both the groups. Hence both diclofenac and tramadol can be used safely and effectively for pain control in AP.
TRIAL REGISTRATION
The trial was registered with clinical trials registry India (Number- CTRI/2018/05/014309).
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Diclofenac
144O8QL0L1
Tramadol
39J1LGJ30J
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
639-648Informations de copyright
© 2019 European Pain Federation - EFIC®.
Références
Aiyer, R., Mehta, N., Gungor, S., & Gulati, A. (2018). A systematic review of NMDA receptor antagonists for treatment of neuropathic pain in clinical practice. The Clinical Journal of Pain, 34, 450-467. https://doi.org/10.1097/AJP.0000000000000547
Balthazar, E. J., Robinson, D. L., Megibow, A. J., & Ranson, J. H. (1990). Acute pancreatitis: Value of CT in establishing prognosis. Radiology, 174(2), 331-336. https://doi.org/10.1148/radiology.174.2.2296641
Banks, P. A., Bollen, T. L., Dervenis, C., Gooszen, H. G., Johnson, C. D., Sarr, M. G., … … Acute Pancreatitis Classification Working Group. (2013). Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus. Gut, 62(1), 102-111. https://doi.org/10.1136/gutjnl-2012-302779
Banks, P. A., & Freeman, M. L.; Practice Parameters Committee of the American College of Gastroenterology. (2006). Practice guidelines in acute pancreatitis. The American Journal of Gastroenterology, 101(10), 2379-2400. https://doi.org/10.1111/j.1572-0241.2006.00856.x
Basurto Ona, X., Rigau Comas, D., & Urrútia, G. (2013). Opioids for acute pancreatitis pain. The Cochrane Database of Systematic Reviews, CD009179. https://doi.org/10.1002/14651858.CD009179.pub2
Bhatia, M., Sidhapuriwala, J. N., Sparatore, A., & Moore, P. K. (2008). Treatment with H2S-releasing diclofenac protects mice against acute pancreatitis-associated lung injury. Shock, 29(1), 84-88. https://doi.org/10.1097/shk.0b013e31806ec26
Bombardo, M., Malagola, E., Chen, R., Rudnicka, A., Graf, R., & Sonda, S. (2018). Ibuprofen and diclofenac treatments reduce proliferation of pancreatic acinar cells upon inflammatory injury and mitogenic stimulation. British Journal of Pharmacology, 175(2), 335-347. https://doi.org/10.1111/bph.13867
Comparing Two Means-Sample Size. (n.d.). Retrieved July 12, 2019, from Select Statistical Consultants website: https://select-statistics.co.uk/calculators/sample-size-calculator-two-means/
Comstedt, P., Storgaard, M., & Lassen, A. T. (2009). The Systemic Inflammatory Response Syndrome (SIRS) in acutely hospitalised medical patients: A cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 17, 67. https://doi.org/10.1186/1757-7241-17-67
Courtney, M. J., & Cabraal, D. (2001). Tramadol vs. diclofenac for posttonsillectomy analgesia. Archives of Otolaryngology-Head & Neck Surgery, 127(4), 385-388. https://doi.org/10.1001/archotol.127.4.385
Crockett, S. D., Wani, S., Gardner, T. B., Falck-Ytter, Y., Barkun, A. N., Crockett, S., … Weinberg, D. (2018). American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis. Gastroenterology, 154(4), 1096-1101. https://doi.org/10.1053/j.gastro.2018.01.032
Gülen, B., Dur, A., Serinken, M., Karcıoğlu, Ö., & Sönmez, E. (2016). Pain treatment in patients with acute pancreatitis: A randomized controlled trial. The Turkish Journal of Gastroenterology, 27(2), 192-196. https://doi.org/10.5152/tjg.2015.150398
Gulen, B., Kocyigit, A., Eken, C., Serinken, M., Karcioglu, O., Dur, A., & Kilic, E. (2016). Oxidative status and DNA damage following analgesic treatment in patients with acute pancreatitis. Clinical Laboratory, 62(7), 1339-1346. https://doi.org/10.7754/Clin.Lab.2015.151203
Jensen, M. P., Chen, C., & Brugger, A. M. (2003). Interpretation of visual analog scale ratings and change scores: A reanalysis of two clinical trials of postoperative pain. The Journal of Pain, 4(7), 407-414. https://doi.org/10.1016/S1526-5900(03)00716-8
Kapoor, K., Repas, K., Singh, V. K., Conwell, D. L., Mortele, K. J., Wu, B. U., & Banks, P. A. (2013). Does the duration of abdominal pain prior to admission influence the severity of acute pancreatitis? Journal of the Pancreas, 14(2), 171-175. https://doi.org/10.6092/1590-8577/1283
Katsinelos, P., Fasoulas, K., Paroutoglou, G., Chatzimavroudis, G., Beltsis, A., Terzoudis, S., … Kountouras, J. (2012). Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: A randomized, double-blind, placebo-controlled trial. Endoscopy, 44(1), 53-59. https://doi.org/10.1055/s-0031-1291440
Mahapatra, S. J., Jain, S., Bopanna, S., Gupta, S., Singh, P., Trikha, A., … Garg, P. K. (2019). Pentazocine, a Kappa-Opioid agonist, is better than diclofenac for analgesia in acute pancreatitis: A randomized controlled trial. The American Journal of Gastroenterology, 114(5), 813-821. https://doi.org/10.14309/ajg.0000000000000224
Mäkelä, A., Kuusi, T., & Schröder, T. (1997). Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scandinavian Journal of Clinical and Laboratory Investigation, 57(5), 401-407. https://doi.org/10.3109/00365519709084587
Ozer Cakir, O., Esen, H., Toker, A., Ataseven, H., Demir, A., & Polat, H. (2015). Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice. International Journal of Clinical and Experimental Medicine, 8(10), 17551-17564.
Ozer Cakir, O., & Findik, S. (2018). Diclofenac sodium treatment ameliorates extrapancreatic organ injuries in a murine model of acute pancreatitis induced by caerulein. Gastroenterology Research and Practice, 2018, 9829208. https://doi.org/10.1155/2018/9829208
Pagliara, L., Tornago, S., Metastasio, J., Peretti, G., Albisetti, W., Thovez, G., & Ferrari, C. (1997). Tramadol compared with diclofenac in traumatic musculoskeletal pain. Current Therapeutic Research, 58(8), 473-480. https://doi.org/10.1016/S0011-393X(97)80039-2
Peiró, A. M., Martínez, J., Martínez, E., de Madaria, E., Llorens, P., Horga, J. F., & Pérez-Mateo, M. (2008). Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain. Pancreatology, 8(1), 25-29. https://doi.org/10.1159/000114852
Pezzilli, R., Morselli-Labate, A. M., & Corinaldesi, R. (2010). NSAIDs and acute pancreatitis: A systematic review. Pharmaceuticals, 3(3), 558-571. https://doi.org/10.3390/ph3030558
Phillip, V., Schuster, T., Hagemes, F., Lorenz, S., Matheis, U., Preinfalk, S., … Huber, W. (2013). Time period from onset of pain to hospital admission and patients' awareness in acute pancreatitis. Pancreas, 42(4), 647-654. https://doi.org/10.1097/MPA.0b013e3182714565
Random Allocation Software. Get the software safe and easy. (n.d.). Retrieved July 15, 2019, from Software Informer website: https://random-allocation-software.software.informer.com/2.0/.
Serrano, J., de Moura, D., Bernardo, W., Ribeiro, I., Franzini, T., de Moura, E., … De Moura, E. (2019). Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis. Endoscopy International Open, 7(4), E477-E486. https://doi.org/10.1055/a-0862-0215
SPSS Software. (2019). Retrieved from https://www.ibm.com/in-en/analytics/spss-statistics-software. July 15, 2019.
Staritz, M., Poralla, T., Manns, M., Meyer Zum Buschenfelde, K. H. (1986). Effect of modern analgesic drugs (tramadol, pentazocine, and buprenorphine) on the bile duct sphincter in man. Gut, 27(5), 567-569. https://doi.org/10.1136/gut.27.5.567
Swaroop, V. S., Chari, S. T., & Clain, J. E. (2004). Severe acute pancreatitis. JAMA, 291(23), 2865-2868. https://doi.org/10.1001/jama.291.23.2865
Tenner, S., Baillie, J., DeWitt, J., & Vege, S. S.; American College of Gastroenterology. (2013). American College of Gastroenterology guideline: Management of acute pancreatitis. The American Journal of Gastroenterology, 108(9), 1400-1415. https://doi.org/10.1038/ajg.2013.218
Tomoda, T., Kato, H., Ueki, T., Akimoto, Y., Hata, H., Fujii, M., … Okada, H. (2019). Combination of diclofenac and sublingual nitrates is superior to diclofenac alone in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology, 156(6), 1753-1760.e1. https://doi.org/10.1053/j.gastro.2019.01.267
Vadivelu, N., Chang, D., Helander, E. M., Bordelon, G. J., Kai, A., Kaye, A. D., … Julka, I. (2017). Ketorolac, oxymorphone, tapentadol, and tramadol: A comprehensive review. Anesthesiology Clinics, 35(2), e1-e20. https://doi.org/10.1016/j.anclin.2017.01.001
Whitcomb, D. C. (2006). Clinical practice. Acute pancreatitis. The New England Journal of Medicine, 354(20), 2142-2150. https://doi.org/10.1056/NEJMcp054958
Wu, S.-D., Zhang, Z.-H., Jin, J.-Z., Kong, J., Wang, W., Zhang, Q., … Wang, M.-F. (2004). Effects of narcotic analgesic drugs on human Oddi's sphincter motility. World Journal of Gastroenterology, 10(19), 2901-2904. https://doi.org/10.3748/wjg.v10.i19.2901
Zhao, X., Bao, J., Hu, C., Ding, H., Liu, X., Mei, Q., & Xu, J. (2014). Effect of diclofenac on the levels of lipoxin A4 and Resolvin D1 and E1 in the post-ERCP pancreatitis. Digestive Diseases and Sciences, 59(12), 2992-2996. https://doi.org/10.1007/s10620-014-3280-6